References
- World Health Organisation. WHO coronavirus disease COVID-19 dashboard. https://covid19.who.int. Accessed March 28, 2021.
- Savastano A, Crincoli E, Savastano M, et al. Peripapillary retinal vascular involvement in early post-COVID-19 patients. J Clin Med. 2020;9(9):2895. doi:https://doi.org/10.3390/jcm9092895.
- Má Z, Banderas García S, Sánchez A. et al. Retinal microvascular abnormalities in patients after COVID-19 depending on disease severity. Br J Ophthalmol. 2020;1–5. doi:https://doi.org/10.1136/bjophthalmol-2020-317953.
- Landecho MF, Yuste JR, Gándara E, et al. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J Intern Med. 2021;289(1):116–120. doi:https://doi.org/10.1111/joim.13156.
- Sawalha K, Adeodokun S, Kamoga GR. COVID-19-induced acute bilateral optic neuritis. J Invest Med High Impact Case Rep 2020;8. doi:https://doi.org/10.1177/2324709620976018.
- Marcos A, Catharino S, Antônio M, et al. COVID-19 related optic neuritis: case report. J Clin Neurol Neurosci. 2017;8. doi:https://doi.org/10.21767/2171-6625.1000176.
- Montesel A, Bucolo C, Mouvet V, Moret E, Eandi CM. Case report: central retinal artery occlusion in a COVID-19 patient. Front Pharmacol. 2020;11:11. doi:https://doi.org/10.3389/fphar.2020.588384.
- Gascon P, Briantais A, Bertrand E, et al. Covid-19-associatedretinopathy: a case report. Ocul Immunol Inflamm. 2020;28(8):1293–1297.doi:https://doi.org/10.1080/09273948.2020.1825751.
- Rebolleda G, Diez-Alvarez L, Casado A, et al. OCT: new perspectives in neuro-ophthalmology. Saudi J Ophthalmol. 2015;29(1):9–25.doi:https://doi.org/10.1016/j.sjopt.2014.09.016.
- François J, Collery AS, Hayek G, et al. Coronavirus disease 2019-associated ocular neuropathy with panuveitis: a case report. JAMA Ophthalmol. 2020. doi:https://doi.org/10.1001/jamaophthalmol.2020.5695.
- Rho J, Dryden SC, McGuffey CD, Fowler BT, Fleming JA. Case of non-arteritic anterior ischemic optic neuropathy with COVID-19. Cureus. 2020;12(12). doi:https://doi.org/10.7759/cureus.11950.
- Kanski J, Bowling B. Kanski’s Clinical Ophthalmology. In:7th ed. London: Elsevier Saunder Limited; 2011: p:796.
- Cevik M, Bamford CGG, Ho A. COVID-19 pandemic—a focused review for clinicians. Clin Microbiol Infect. 2020;26(7):842–847. doi:https://doi.org/10.1016/j.cmi.2020.04.023.
- Hashimoto H, Hata M, Kashii S, et al. Analysis of retinal nerve fibre thickening in progressive and non-progressive non-arteritic anterior ischaemic optic neuropathy using optical coherence tomography. Neuro-Ophthalmology.2020;44(5):307–314.doi:https://doi.org/10.1080/01658107.2020.1755991.
- Bertoli F, Veritti D, Danese C, et al. Ocular findings in COVID-19 patients: a review of direct manifestations and indirect effects on the eye. J Ophthalmol. 2020;2020. doi:https://doi.org/10.1155/2020/4827304.
- Abrishami M, Emamverdian Z, Shoeibi N. et al. Optical coherence tomography angiography analysis of the retina in patients recovered from COVID-19: a case-control study. Can J Ophthalmol. 2020;56:24–30. doi:https://doi.org/10.1016/j.jcjo.2020.11.006.
- Lee TH, Heo H, Park SW. Clinical usefulness of spectral-domain optical coherence tomography in glaucoma and NAION. Chonnam Med J. 2016;52(3):194. doi:https://doi.org/10.4068/cmj.2016.52.3.194.
- Zago Filho LA, Lima LH, Melo GB, Zett C, Farah ME. Vitritis and outer retinal abnormalities in a patient with COVID-19. Ocul Immunol Inflamm. 2020;28(8):1298–1300. doi:https://doi.org/10.1080/09273948.2020.1821898.